Lv1
18 积分 2023-01-30 加入
Developing selective PI3K degraders to modulate both kinase and non-kinase functions
17天前
已完结
Target and tissue selectivity of PROTAC degraders
2个月前
已完结
The Role of PI3K Isoforms in Autoimmune Disease
2个月前
已完结
Inavolisib: First Approval
2个月前
已完结
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
2个月前
已完结
Overall Survival with Inavolisib in PIK3CA -Mutated Advanced Breast Cancer
2个月前
已完结
BBO-10203 inhibits tumor growth without inducing hyperglycemia by blocking RAS-PI3Kα interaction
3个月前
已完结
Covalent inhibitors of the PI3Kα RAS binding domain impair tumor growth driven by RAS and HER2
3个月前
已完结
Molecular glues that facilitate RAS binding to PI3Kα promote glucose uptake without insulin
3个月前
已完结
Targeting a lineage-specific PI3Kɣ–Akt signaling module in acute myeloid leukemia using a heterobifunctional degrader molecule
3个月前
已完结
皖公网安备34019202002308
